Michael W. Climo

4.2k total citations · 1 hit paper
42 papers, 3.0k citations indexed

About

Michael W. Climo is a scholar working on Infectious Diseases, Clinical Biochemistry and Epidemiology. According to data from OpenAlex, Michael W. Climo has authored 42 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Infectious Diseases, 21 papers in Clinical Biochemistry and 13 papers in Epidemiology. Recurrent topics in Michael W. Climo's work include Antimicrobial Resistance in Staphylococcus (30 papers), Bacterial Identification and Susceptibility Testing (21 papers) and Clostridium difficile and Clostridium perfringens research (9 papers). Michael W. Climo is often cited by papers focused on Antimicrobial Resistance in Staphylococcus (30 papers), Bacterial Identification and Susceptibility Testing (21 papers) and Clostridium difficile and Clostridium perfringens research (9 papers). Michael W. Climo collaborates with scholars based in United States, Netherlands and Philippines. Michael W. Climo's co-authors include Gordon L. Archer, Edward S. Wong, Roberto L. Patron, Trish M. Perl, David K. Warren, Kent A. Sepkowitz, Loreen A. Herwaldt, John A. Jernigan, Victoria J. Fraser and Deborah S. Yokoe and has published in prestigious journals such as New England Journal of Medicine, Annals of Internal Medicine and Clinical Infectious Diseases.

In The Last Decade

Michael W. Climo

42 papers receiving 2.9k citations

Hit Papers

Effect of Daily Chlorhexidine Bathing on Hospital-Acquire... 2013 2026 2017 2021 2013 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael W. Climo United States 29 1.8k 815 707 680 396 42 3.0k
Bala Hota United States 30 2.1k 1.1× 875 1.1× 995 1.4× 430 0.6× 411 1.0× 73 3.9k
Gail Potter-Bynoe United States 22 1.7k 0.9× 665 0.8× 621 0.9× 383 0.6× 359 0.9× 38 3.1k
John D. Rihs United States 27 1.2k 0.7× 805 1.0× 1.3k 1.9× 483 0.7× 350 0.9× 47 3.2k
Connie Price United States 30 2.0k 1.1× 706 0.9× 949 1.3× 340 0.5× 215 0.5× 99 4.0k
M.W. Casewell United Kingdom 35 1.8k 1.0× 686 0.8× 947 1.3× 681 1.0× 343 0.9× 81 4.3k
Denise Gravel Canada 26 1.5k 0.8× 398 0.5× 864 1.2× 323 0.5× 365 0.9× 60 2.5k
John Coia United Kingdom 33 2.0k 1.1× 446 0.5× 824 1.2× 608 0.9× 242 0.6× 104 3.8k
Mondell L. Beach United States 21 1.3k 0.7× 996 1.2× 750 1.1× 652 1.0× 215 0.5× 31 2.8k
Mary‐Claire Roghmann United States 36 2.2k 1.2× 1.0k 1.3× 1.2k 1.7× 529 0.8× 384 1.0× 102 3.8k
M. Lindsay Grayson Australia 35 1.6k 0.9× 636 0.8× 1.4k 2.0× 403 0.6× 275 0.7× 95 4.9k

Countries citing papers authored by Michael W. Climo

Since Specialization
Citations

This map shows the geographic impact of Michael W. Climo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael W. Climo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael W. Climo more than expected).

Fields of papers citing papers by Michael W. Climo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael W. Climo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael W. Climo. The network helps show where Michael W. Climo may publish in the future.

Co-authorship network of co-authors of Michael W. Climo

This figure shows the co-authorship network connecting the top 25 collaborators of Michael W. Climo. A scholar is included among the top collaborators of Michael W. Climo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael W. Climo. Michael W. Climo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Cosgrove, Sara E., Susan K. Seo, Maureen Bolon, et al.. (2012). Evaluation of Postprescription Review and Feedback as a Method of Promoting Rational Antimicrobial Use: A Multicenter Intervention. Infection Control and Hospital Epidemiology. 33(4). 374–380. 66 indexed citations
3.
Kreisel, Kristen, O. Colin Stine, J. Kristie Johnson, et al.. (2011). USA300 methicillin-resistant Staphylococcus aureus bacteremia and the risk of severe sepsis: is USA300 methicillin-resistant Staphylococcus aureus associated with more severe infections?. Diagnostic Microbiology and Infectious Disease. 70(3). 285–290. 32 indexed citations
4.
Kreisel, Kristen, Mary‐Claire Roghmann, Michelle Shardell, et al.. (2010). Assessment of the 48-Hour Rule for Identifying Community-Associated Methicillin-Resistant Staphylococcus aureus Infection Complicated by Bacteremia. Infection Control and Hospital Epidemiology. 31(6). 657–659. 2 indexed citations
5.
Kreisel, Kristen, J. Kristie Johnson, O. Colin Stine, et al.. (2010). Illicit Drug Use and Risk for USA300 Methicillin-ResistantStaphylococcus aureusInfections with Bacteremia. Emerging infectious diseases. 16(9). 1419–1427. 6 indexed citations
7.
Bolon, Maureen, David C. Hooper, Kurt Stevenson, et al.. (2009). Improved Surveillance for Surgical Site Infections after Orthopedic Implantation Procedures: Extending Applications for Automated Data. Clinical Infectious Diseases. 48(9). 1223–1229. 75 indexed citations
8.
Fox, Paige M., Michael W. Climo, & Gordon L. Archer. (2007). Lack of Relationship between Purine Biosynthesis and Vancomycin Resistance in Staphylococcus aureus : a Cautionary Tale for Microarray Interpretation. Antimicrobial Agents and Chemotherapy. 51(4). 1274–1280. 18 indexed citations
9.
Weber, Stephen G., Susan S. Huang, Shannon Oriola, et al.. (2007). Legislative mandates for use of active surveillance cultures to screen for methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci: Position statement from the Joint SHEA and APIC Task Force. American Journal of Infection Control. 35(2). 73–85. 94 indexed citations
10.
Huang, Susan S., Sheryl L. Rifas‐Shiman, David K. Warren, et al.. (2007). Improving Methicillin‐ResistantStaphylococcus aureusSurveillance and Reporting in Intensive Care Units. The Journal of Infectious Diseases. 195(3). 330–338. 86 indexed citations
11.
Federspiel, Jerome J., et al.. (2007). Selective Use of Intranasal Mupirocin and Chlorhexidine Bathing and the Incidence of Methicillin-Resistant Staphylococcus aureus Colonization and Infection Among Intensive Care Unit Patients. Infection Control and Hospital Epidemiology. 28(10). 1155–1161. 106 indexed citations
12.
Weber, Stephen G., Susan S. Huang, Shannon Oriola, et al.. (2007). Legislative Mandates for Use of Active Surveillance Cultures to Screen for Methicillin-ResistantStaphylococcus aureusand Vancomycin-Resistant Enterococci: Position Statement From the Joint SHEA and APIC Task Force. Infection Control and Hospital Epidemiology. 28(3). 249–260. 85 indexed citations
13.
Warren, David K., Deborah S. Yokoe, Michael W. Climo, et al.. (2006). Preventing Catheter-Associated Bloodstream Infections: A Survey of Policies for Insertion and Care of Central Venous Catheters From Hospitals in the Prevention Epicenter Program. Infection Control and Hospital Epidemiology. 27(1). 8–13. 46 indexed citations
14.
Warren, David K., Sara E. Cosgrove, Daniel J. Diekema, et al.. (2006). A Multicenter Intervention to Prevent Catheter-Associated Bloodstream Infections. Infection Control and Hospital Epidemiology. 27(7). 662–669. 105 indexed citations
15.
Climo, Michael W., Daniel J. Diekema, Victoria J. Fraser, et al.. (2005). Varying Rates of Clostridium Difficile-Associated Diarrhea at Prevention Epicenter Hospitals. Infection Control and Hospital Epidemiology. 26(8). 676–679. 35 indexed citations
16.
Climo, Michael W., Daniel J. Diekema, David K. Warren, et al.. (2003). Prevalence of the Use of Central Venous Access Devices Within and Outside of the Intensive Care Unit: Results of a Survey Among Hospitals in the Prevention Epicenter Program of the Centers for Disease Control and Prevention. Infection Control and Hospital Epidemiology. 24(12). 942–945. 116 indexed citations
17.
Climo, Michael W., et al.. (2002). Staphylococcus aureus carriage and health care-acquired infection. Current Infectious Disease Reports. 4(6). 498–504. 4 indexed citations
18.
Archer, Gordon L., et al.. (2002). Combinations of Lysostaphin with β-Lactams Are Synergistic against Oxacillin-Resistant Staphylococcus epidermidis. Antimicrobial Agents and Chemotherapy. 46(6). 2017–2020. 56 indexed citations
19.
Climo, Michael W., et al.. (1999). Seeking Vancomycin Resistant Staphylococcus aureus among Patients with Vancomycin-Resistant Enterococci. Clinical Infectious Diseases. 29(6). 1566–1568. 42 indexed citations
20.
Climo, Michael W., et al.. (1997). An Outbreak of Pseudomonas aeruginosa Related to Contaminated Urodynamic Equipment. Infection Control and Hospital Epidemiology. 18(7). 509–510. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026